Weekly Warm up with Sinapse!

PIRATE’S SHARE: PIRACY IS NOT MUSIC TO MANY EARS

… In an article published by RIAA, the revenue from digital formats of music was about US$ 4.4B in 2013, and is growing at a exponential rate. Despite the increasing numbers, a large portion of potential revenue from digital exploitation is lost due to piracy. The share of digital music revenues is estimated to be more than 90% and is expected to touch INR 18B in 2015.

LEAD IN PAINT V. LEAD IN BULLET – WE ARE ALL CHARLIE

… The Charlie Hebdo incident has proved that all it takes to bring the world together is the stroke of a brush. “Je suis Charlie” (I am Charlie), has become the singular voice of millions across the globe.

Continue reading Weekly Warm up with Sinapse!

facebooktwittergoogle_plusredditpinterestlinkedinmailby feather

Roche’s backbone rendered brittle by Indian Patent Office

The Chennai Patent Office revoked Hoffmann-La-Roche’s patent on its osteoporosis drug, Bonviva, in response to post grant opposition filed by Indian drug maker, Cipla Global Ltd. The drug in question comprises Ibandronate Sodium, used to treat patients suffering from metastatic cancer, associated skeletal fractures and osteoporosis and also for the treatment and prevention of osteoporosis in post-menopausal women. Osteoporosis is the progressive bone disease caused by decrease in bone mass making bones extremely weak and fragile, leading to increased risk of fractures.  The drug is marketed as Boniva in the US, Bondronat in Europe and Bonviva in Asia.

The patent in dispute bearing number 208,718, was granted by the patent office in 2007 based on an application filed by Roche in 2001. It covers oral pharmaceutical composition of the active ingredient Ibandronate Sodium with a controlled dissolution rate for the treatment of Osteoporosis. A post grant opposition filed by Cipla in 2008, was refused by the patent office in 2010 upholding Roche’s patent. Cipla appealed to the IPAB, which set aside patent office’s order, asking them to reconsider the matter based on expert evidence and recommendations of the opposition board.

Continue reading Roche’s backbone rendered brittle by Indian Patent Office

facebooktwittergoogle_plusredditpinterestlinkedinmailby feather

Pirates of Bollywood Free Giveaway Winners to be picked tomorrow

Dear Readers,

Last year, Sinapse opened up, for its Readers, a lucky draw contest – Free Giveaway of Dr. Kalyan Kankanala’s second law thriller, Pirates of Bollywood for 5 lucky winners (for those in India and 10 copies of the EPUB version for those outside of India). Registration was simple but the reward is a copy of the new hot-selling book Pirates of Bollywood, released into stands just under a fortnight ago!

I’m sure you’re all eagerly awaiting the results. We will be drawing lots with names of all those who so keenly registered. Just give it one more day and the results will be revealed to you tomorrow, right here, on Sinapse!

Check this page again tomorrow for more!

Good Luck,

Editor

facebooktwittergoogle_plusredditpinterestlinkedinmailby feather

Weekly Warm up with Sinapse!

GOOGLE V. SPAIN – SPANISH PUBLISHERS SUFFER AS GOOGLE NEWS CLOSES OPERATIONS

…A new Copyright law which has made it mandatory for Google, Yahoo and other news aggregators to pay licensing fee to all news publishers for using their stories or snippets in Google News, results in Google cutting its operations in Spain. However, the regulation allowed publishers to opt in to Google’s index, and prevent Google from paying licensing fee.

COPYRIGHT REGULATION TO ALLOW PRIVATE COPYING; TO FACE IRE OF UK MUSIC INDUSTRY

…In UK, music can be legally copied to a private system but a strong resistance was noticed from the UK music industry. The law came into force on October 1, 2015.

Continue reading Weekly Warm up with Sinapse!

facebooktwittergoogle_plusredditpinterestlinkedinmailby feather

Drug Humira turns Rheumatic for Abbott Biotechnology

The Indian Patent Office on December 31, 2014 set aside its order of granting a Patent to Abbott Biotechnology for its drug, Humira, in light of pre-grant opposition filed by Glenmark Pharmaceuticals. In November, 2003, Abbott had filed a patent application No. 526/DELNP/2005 for its drug named Humira, a formulation of human antibodies for treating Rheumatoid Arthritis. Glenmark filed a pre-grant opposition to this application in September, 2008. Since this was not brought to the notice of the Controller, Patent No. 234,555 was granted to said invention in June, 2009.

In July, 2009, this discrepancy was brought to the notice of the Controller by Glenmark. The Controller cancelled the Patent grant with immediate effect through a letter dated October 30, 2009. In the meantime, Glenmark also filed a Writ Petition before the Delhi High Court against the order of the Controller granting the Patent. However, the same was disposed of by the Court as infructuous in light of the Order of the Controller dated October 30, 2009 cancelling the patent grant.

Continue reading Drug Humira turns Rheumatic for Abbott Biotechnology

facebooktwittergoogle_plusredditpinterestlinkedinmailby feather

Pirate’s Share: Piracy is Not Music to Many Ears

The revenues from digital formats of music, as per an article published by RIAA, was about US$ 4.4B in 2013, and is growing at a exponential rate. The evolution of novel modes and means of digital exploitation has opened doors to music creators and owners across the world, as well as pirates. With more than 500 record labels releasing recordings in more than 20 languages, the music business in India is not only very large, but also diverse. The share of digital music revenues is estimated to be more than 90% and is expected to touch INR 18B in 2015.

Despite the increasing numbers, a large portion of potential revenue from digital exploitation is lost due to piracy. RIAA estimates that since the peer to peer file sharing platform, Napster, came into play in 1999, the industry has lost 56% of revenue, dropping from US$ 14.6B to US$ 7.0B by 2013. In India, the impact of piracy on the music industry is estimated to be 54% of the potential revenue. These numbers are staggering, and assuming that they are close to reality, the music industry in India is losing close to INR 1900 Crores due to piracy.

Continue reading Pirate’s Share: Piracy is Not Music to Many Ears

facebooktwittergoogle_plusredditpinterestlinkedinmailby feather

New Copyright Law: Parody is legal if Judge thinks it’s funny

Here is the next post in the series of Student Blog Contest. This post is authored by Nitish Chaudhary.

Imagine, one day, if Copyright Laws were changed to account for the legality of a parody, a caricature or a pastiche[i], based on whether a Judge found it funny. For the citizens of UK, that day was October 1, 2014. Amendments to the Copyright, Designs and Patents Act, 1988, have done exactly this. Along with changes in Parody Law, there’s a new freedom by law to create personal copies, for private use[ii]. The UK Copyright Law, known to be anything but relaxed, has seen a crucial change, as can be seen below:

Copyright Law imparts unto a user the right to copy, bound by the following restrictions (not relating to computer programs):

  • The original source of the copy must have either been validly purchased or gifted; (A person has to legally own the original material before they can copy it),
  • The copy should be for ‘private use’, including for backup, shifting data, remote-access etc.; (i.e., for personal use by the owner of original, hence a personal copy),
  • The copy should not be used for commercial purpose, directly or indirectly; (No means no),
  • If the original material is transferred to another person, the right to personal copies is lost and they have to be destroyed; (If a person no longer owns the original, the copies can’t be used/owned either).

Continue reading New Copyright Law: Parody is legal if Judge thinks it’s funny

facebooktwittergoogle_plusredditpinterestlinkedinmailby feather

Astrazeneca to retain Sweetness of Onglyza

Aurobindo Pharma, USA, has been dragged to the Court for patent infringement by Astrazeneca. The suit filed is against the ANDA (Abbreviated New Drug Application) filed by Aurobindo Pharma with the USFDA with regard to seeking the market approval for Saxagliptin hydrochloride tablets before the expiry of its US patent. Aurobindo Pharma plans to market the generic versions of Saxagliptin hydrochloride tablets of 2.5 mg and 5 mg strengths.

Astrazeneca is the sole marketer of Saxagliptin hydrochloride tablets having got marketing approval from the FDA through an NDA (New Drug Application) and markets the drug in the US under the brand name Onglyza. Onglyza (saxagliptin) is an oral dipeptidyl peptidase 4 (DPP-4) inhibitor used for the treatment of Type-2 Diabetes Mellitus. These drugs act by promoting insulin secretion by the pancreas and control the liver from excess sugar production. It is a popular drug that effectively controls blood sugar without weight gain like other anti-diabetics.

Continue reading Astrazeneca to retain Sweetness of Onglyza

facebooktwittergoogle_plusredditpinterestlinkedinmailby feather

Louisiana State Univ to double investments for moving Innovation into market

In January this year, Louisiana State University (LSU), established LSU LIFT (Leveraging Innovation for Technology Transfer) Fund, which offers bi-annual funding to LSU faculty members on a competitive basis, to effectively transfer innovation out of the lab and into the market. The board also agreed to continually support the LSU LIFT Fund by assigning 5% of the university’s future IP licensing income to the new fund.

In Round 1 of funding, the program attracted 47 applications out of which 15 grants were awarded, with a total funding of over US$ 500,000 in support of further commercialization of innovation. Round 2 is currently in progress and the awardees will be announced in the beginning of 2015. In October, 2014, the Research Park Corporation commenced a US$ 250,000 LSU Re-LIFT2 program that would help the aspirants who could not obtain the funding in Round 1, but had promising projects.

Continue reading Louisiana State Univ to double investments for moving Innovation into market

facebooktwittergoogle_plusredditpinterestlinkedinmailby feather

Google vs. Spain – Spanish publishers suffer as Google News closes Operations

Last week, Google closed its operations in Spain, in response to the new Copyright Law which has made it mandatory for Google, Yahoo and other news aggregators to pay licensing fee to all news publishers for using their stories or snippets in Google News. The regulation, expected to come into effect in 2015, will deal with websites that share pirated content. As per the law, Spanish Government will have the authority to penalize websites up to US$ 750,000 for directing links to the pirated content.

Media companies from Anti Google Lobbying Group, AEDE (Association of Editors of Spanish Dailies) which pushed the new law, are now asking the Spanish Government to prevent Google from closing its news service. Today, Google News service is offered in more than 35 languages and covers around 70 international editions. Google news had been directing a great deal of traffic to these media companies and a lot of them will have to turn to paid Google AdWords to make up for losses caused from their absence in Google News. On the other hand, for a tech giant like Google, Spain is a pretty small market.

Continue reading Google vs. Spain – Spanish publishers suffer as Google News closes Operations

facebooktwittergoogle_plusredditpinterestlinkedinmailby feather